Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 7, 2008, Pages 1019-1024

  Bargnoux, Anne Sophie ^a   Klouche, Kada ^a   Fareh, Jeanette ^b   Barazer, Isabelle ^c   Villard Saussine, Sylvie ^b   Dupuy, Anne Marie ^a   Leray Moragues, Hélène ^a   Giuliani, Isabelle ^d   Canaud, Bernard ^a   Cristol, Jean Paul ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b CNRS   (France)

^c CH   (France)

^d Bio Rad   (France)

Author keywords

Brain natriuretic peptide (BNP); Dialysis; Hemodiafiltration; N terminal proBNP; ProBNP

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART INDEX; HEART VENTRICLE FUNCTION; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RENAL DIALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 47349123484     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.192     Document Type: Article

References (22)

1. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006;92:843-9.
2. Giuliani I, Rieunier F, Larue C, Delagneau JF, Granier C, Pau B, et al. Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 2006;52:1054-61.
3. McCullough PA, Sandberg KR. Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med 2003;4(Suppl 4):S13-9.
4. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001;12:1508-15.
5. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995;5:2024-31.
6. Apple FS, Murakami MM, Pearce LA, Herzog CA. Multibiomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004;50:2279-85.
7. Luchner A, Hengstenberg C, Lowel H, Riegger GA, Schunkert H, Holmer S. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 2005;46:118-23.
8. Fagugli RM, Palumbo B, Ricciardi D, Pasini P, Santirosi P, Vecchi L, et al. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract 2003;95:c60-6.
9. Safley DM, Awad A, Sullivan RA, Sandberg KR, Mourad I, Boulware M, et al. Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function. Adv Chronic Kidney Dis 2005;12:117-24.
10. Wahl HG, Graf S, Renz H, Fassbinder W. Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem 2004;50:1071-4.
11. Goetze JP, Jensen G, Moller S, Bendtsen F, Rehfeld JF, Henriksen JH. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 2006;36:8-15.
12. Kroll MH, Srisawasdi P. The clearance of BNP modeled using the NT-proBNP-BNP relationship. Biosystems 2007;88:147-55.
13. Khan IA, Fink J, Nass C, Chen H, Christenson R, deFilippi CR. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am J Cardiol 2006;97:1530-4.
14. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4:1205-13.
15. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-8.
16. Vasan RS, Benjamin EJ, Larson MG, Leip EP, Wang TJ, Wilson PW, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham Heart Study. J Am Med Assoc 2002;288:1252-9.
17. Vickery S, Price CP, John RI, Abbas NA, Webb MC, Kempson ME, et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis 2005;46:610-20.
18. Sheen V, Bhalla V, Tulua-Tata A, Bhalla MA, Weiss D, Chiu A, et al. The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. Am Heart J 2007;153:244, e1-5.
19. Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit. J Am Coll Cardiol 2005;45:1667-71.
20. Martin LC, Barretti P, Cornejo IV, Felipe MJ, Forti AH, Matsubara BB, et al. Influence of fluid volume variations on the calculated value of the left ventricular mass measured by echocardiogram in patients submitted to hemodialysis. Ren Fail 2003;25:43-53.
21. Krieter DH, Lemke HD, Canaud B, Wanner C. Beta(2)-microglobulin removal by extracorporeal renal replacement therapies. Biochim Biophys Acta 2005;1753:146-53.
22. Ojanen S, Virtanen V, Kööbi T, Mustonen J, Pasternack A. The effect of isolated ultrafiltration on Doppler-derived indices of left ventricular diastolic function. Nephrol Dial Transplant 2004;19:3130-6.